| Dr Jessica Warren Grayson, MD | |
|
619 19th St S, Birmingham, AL 35249 | |
| (205) 934-4011 | |
| Not Available |
| Full Name | Dr Jessica Warren Grayson |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 11 Years |
| Location | 619 19th St S, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043553340 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 33834 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Alabama Hospital | Birmingham, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Alabama Health Services Foundation, Pc | 1951213107 | 2344 |
News Archive
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that its SGX301 (synthetic hypericin) development program for the first-line treatment of cutaneous T-cell lymphoma (CTCL) has received "Fast Track" designation from the US Food and Drug Administration.
Alkermes plc today announced the initiation of the second phase 2 study of ALKS 3831, a novel, oral, broad-spectrum antipsychotic medicine in development for schizophrenia.
Merial today announced the introduction of a new inactivated vaccine, GALLIMUNE Flu H5N9, developed and shown to be effective specifically for use against the highly pathogenic avian influenza virus H5N1 that has caused devastating economic losses in the poultry industry in Asia, and which has been linked to the deaths of over 29 humans.
There have been conflicting reports on health benefits and harm caused by drinking alcohol. A new study from Japanese researchers has proven that taking one drink a day for a decade or two drinks for five years can raise the risk of getting cancers by 5 percent. The study titled "Light to moderate amount of lifetime alcohol consumption and risk of cancer in Japan," was published in the latest issue of the journal Cancer.
UC Davis Health researchers were surprised to find that methamphetamine use is not linked with worse health outcomes among burn patients. However, meth use was associated with significantly worse conditions for those patients after their release from the hospital.
› Verified 3 days ago
| Entity Name | University Of Alabama Health Services Foundation, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that its SGX301 (synthetic hypericin) development program for the first-line treatment of cutaneous T-cell lymphoma (CTCL) has received "Fast Track" designation from the US Food and Drug Administration.
Alkermes plc today announced the initiation of the second phase 2 study of ALKS 3831, a novel, oral, broad-spectrum antipsychotic medicine in development for schizophrenia.
Merial today announced the introduction of a new inactivated vaccine, GALLIMUNE Flu H5N9, developed and shown to be effective specifically for use against the highly pathogenic avian influenza virus H5N1 that has caused devastating economic losses in the poultry industry in Asia, and which has been linked to the deaths of over 29 humans.
There have been conflicting reports on health benefits and harm caused by drinking alcohol. A new study from Japanese researchers has proven that taking one drink a day for a decade or two drinks for five years can raise the risk of getting cancers by 5 percent. The study titled "Light to moderate amount of lifetime alcohol consumption and risk of cancer in Japan," was published in the latest issue of the journal Cancer.
UC Davis Health researchers were surprised to find that methamphetamine use is not linked with worse health outcomes among burn patients. However, meth use was associated with significantly worse conditions for those patients after their release from the hospital.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jessica Warren Grayson, MD Po Box 55310, Birmingham, AL 35255-5310 Ph: () - | Dr Jessica Warren Grayson, MD 619 19th St S, Birmingham, AL 35249 Ph: (205) 934-4011 |
News Archive
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that its SGX301 (synthetic hypericin) development program for the first-line treatment of cutaneous T-cell lymphoma (CTCL) has received "Fast Track" designation from the US Food and Drug Administration.
Alkermes plc today announced the initiation of the second phase 2 study of ALKS 3831, a novel, oral, broad-spectrum antipsychotic medicine in development for schizophrenia.
Merial today announced the introduction of a new inactivated vaccine, GALLIMUNE Flu H5N9, developed and shown to be effective specifically for use against the highly pathogenic avian influenza virus H5N1 that has caused devastating economic losses in the poultry industry in Asia, and which has been linked to the deaths of over 29 humans.
There have been conflicting reports on health benefits and harm caused by drinking alcohol. A new study from Japanese researchers has proven that taking one drink a day for a decade or two drinks for five years can raise the risk of getting cancers by 5 percent. The study titled "Light to moderate amount of lifetime alcohol consumption and risk of cancer in Japan," was published in the latest issue of the journal Cancer.
UC Davis Health researchers were surprised to find that methamphetamine use is not linked with worse health outcomes among burn patients. However, meth use was associated with significantly worse conditions for those patients after their release from the hospital.
› Verified 3 days ago
Dr. Grayson K Rodgers, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2700 10th Ave S Ste 502, Birmingham, AL 35205 Phone: 205-933-2951 Fax: 205-933-5893 | |
Brian Kulbersh, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1940 Elmer J Bissell Rd, Birmingham, AL 35243 Phone: 205-638-4949 Fax: 205-638-4982 | |
Dr. Richard Kailean Mchugh, MD, PHD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2000 6th Ave S, The Kirklin Clinic, Birmingham, AL 35233 Phone: 205-801-8000 | |
Paul F Castellanos, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-6600 | |
Dr. David Michael Walters, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1809 Gadsden Hwy, Birmingham, AL 35235 Phone: 205-838-3755 Fax: 205-838-3755 | |
Do Yeon Cho, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2000 6th Ave S, Birmingham, AL 35233 Phone: 205-934-9999 |